PetMed Express, Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-57.3M | $-6.3M | $-7.5M | $5.1M | $18.7M | $23.9M | $25.9M | $37.7M |
| Depreciation & Amortization | $9.4M | $7.0M | $7.1M | $3.5M | $2.7M | — | — | — |
| Depreciation | — | $5.1M | $5.1M | $3.5M | $2.7M | $2.4M | $2.3M | $2.2M |
| Amortization | $2.0M | $2.0M | $2.0M | $0 | — | — | — | — |
| Stock-Based Compensation | $1.4M | $-6.6M | $6.9M | $6.6M | $4.5M | $3.3M | $2.8M | $3.1M |
| Net Cash from Operating Activities | $-28.4M | $4.7M | $4.3M | $27.8M | $18.5M | $40.1M | $38.8M | $45.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $4.6M | $5.1M | $4.5M | $5.3M | $1.8M | $2.4M | $2.3M | $620.0K |
| Business Acquisitions | $0 | $0 | $35.9M | $0 | $0 | — | — | — |
| Net Cash from Investing Activities | $-4.6M | $-5.1M | $-40.7M | $-10.3M | $-1.8M | $-2.4M | $-2.3M | $-620.0K |
| Financing Activities | ||||||||
| Dividends Paid | $21.0K | $181.0K | $12.4M | $24.5M | $24.4M | $22.7M | $21.8M | $21.9M |
| Stock Repurchases | — | — | — | — | $0 | $0 | $11.5M | $0 |
| Net Cash from Financing Activities | $-299.0K | $-181.0K | $-12.4M | $-24.5M | $-24.4M | $-22.7M | $-33.3M | $-21.9M |
| Net Change in Cash | $-33.3M | $-576.0K | $-48.8M | $-7.0M | $-7.6M | $15.0M | $3.2M | $22.6M |
| Free Cash Flow | $-33.0M | $-395.0K | $-194.0K | $22.5M | $16.7M | $37.6M | $36.5M | $44.5M |